✦ LIBER ✦

Improved neurological outcome in children with chronic renal disease from infancy

✍ Scribed by Abdelaziz Elzouki; James Carroll; Dusan Butinar; Allie Moosa

Publisher: Springer
Year: 1994
Tongue: English
Weight: 663 KB
Volume: 8
Category: Article
ISSN: 0931-041X
DOI: 10.1007/bf00865479

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurologic development of children with

Neurologic development of children with severe chronic renal failure from infancy

✍ Martin S. Polinsky; Bruce A. Kaiser; Jean B. Stover; Maria Frankenfield; H. Jorg 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 871 KB

Improving renal outcomes in chronic anem

Improving renal outcomes in chronic anemia: Learning from paroxysmal nocturnal hemoglobinuria

✍ Antonio Guasch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

Neurocognitive outcomes in children with

Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors

✍ Gerson, Arlene C. ;Butler, Robert ;Moxey-Mims, Marva ;Wentz, Alicia ;Shinnar, Sh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract Given the rise in chronic kidney disease (CKD) in both children and adults, CKD has recently been targeted as a public health priority. Childhood onset kidney disease is generally a noncurable and progressive condition that leads to kidney failure by early adulthood. Fortunately, improv

Lipoprotein(a) serum levels and apolipop

Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease

✍ U. Querfeld; M. Lang; J. B. Friedrich; B. Kohl; W. Fiehn; K. Schärer 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 81 KB

Recombinant erythropoietin (Epogen) impr

Recombinant erythropoietin (Epogen) improves cardiac exercise performance in children with end-stage renal disease

✍ Gerard R. Martin; Jose R. Ongkingo; Mary E. Turner; Elaine S. Skurow; Edward J. 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 592 KB

Linear growth improves during infliximab

Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease

✍ Thomas D. Walters; Ashley R. Gilman; Anne M. Griffiths 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Background: The efficacy of infliximab as maintenance therapy in patients with otherwise chronically active crohn's disease (cd) is well established. data concerning the linear growth response are sparse and can only be accrued in children. ## Methods: From september 2000 to february 2004, 32